TOTUSRX, INC. — Form D/A
TOTUSRX, INC. of LONGMONT, CO, a company, filed a Form D amendment with the SEC on 2018-11-29. The offering totals $2.0M, of which $550K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-11-29
- Form: D/A
- Accession: 0001717735-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $550K
- Remaining: $1.4M
- Minimum investment: $5K
- Investors: 47
- Date of first sale: 2017-09-10
- Security types: debt
- Revenue range: $1 - $1,000,000
- SEC file number: 021-295310
Issuer
- Name: TOTUSRX, INC.
- CIK: 0001717735
- Entity type: Corporation
- Jurisdiction: COLORADO
- Incorporated: 2016
- Address: 4051 CAMELOT CIRCLE, LONGMONT, CO, 80504
- Phone: 303-517-8981
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| CRAIG NORMAN CHANGSTROM | Executive Officer | LOVELAND, CO |
| KEVIN MICHAEL CONLON | Executive Officer | BERTHOUD, CO |
| GEOFFREY THOMAS WILLIAMSON | Executive Officer | PALO ALTO, CA |
Other filings by this issuer (1)
More